메뉴 건너뛰기




Volumn 58, Issue 9, 1996, Pages 721-734

Modulation of NMDA and dopaminergic neurotransmissions by sigma ligands: Possible implications for the treatment of psychiatric disorders

Author keywords

Depression; Dopamine; NMDA; Schizophrenia; Sigma receptor

Indexed keywords

1,3 BIS(2 METHYLPHENYL)GUANIDINE; 2 [4 METHOXY 3 (2 PHENYLETHOXY)PHENYL] N,N DIPROPYLETHYLAMINE; ALPHA (4 FLUOROPHENYL) 4 (5 FLUORO 2 PYRIMIDINYL) 1 PIPERAZINEBUTANOL; ANTIDEPRESSANT AGENT; CLORGYLINE; DOPAMINE RECEPTOR; FLUOXETINE; GLUTAMATE RECEPTOR; HALOPERIDOL; IGMESINE; L 687384; N ALLYLNORMETAZOCINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROLEPTIC AGENT; NEUROPEPTIDE Y; OPIPRAMOL; PENTAZOCINE; PEPTIDE YY; PHENCYCLIDINE; PHENCYCLIDINE RECEPTOR; PRECLAMOL; RECEPTOR SUBTYPE; RIMCAZOLE; SELEGILINE; SERTRALINE; SIGMA OPIATE RECEPTOR; SIGMA OPIATE RECEPTOR LIGAND; SPIPERONE; TRIFLUOPERAZINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

EID: 0029671401     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(95)02248-1     Document Type: Short Survey
Times cited : (138)

References (179)
  • 56
    • 0002763857 scopus 로고
    • Y. Itzhak (ed), Academic Press, New York
    • W.S. TAM, Sigma receptors, Y. Itzhak (ed), 191-204, Academic Press, New York (1994).
    • (1994) Sigma Receptors , pp. 191-204
    • Tam, W.S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.